Vaccine and Clinical Trials

Plant-Based Vaccines

Submit Abstract Register Now

The plant-based vaccine method works by isolating a specific antigen protein that can trigger the human immune response from the targeted vaccine. A gene from the protein is transferred to bacteria which are used to infect plant cells. Scientists and researchers are driven more towards the production of safer, easier, and more effective vaccines such as plant-based vaccines for treating severe diseases. The plant-based human vaccines are not commercialized as of now but many viral and bacterial subunit vaccines are in the production stages which are attempted in transgenic plants. Compared to conventional vaccine methods, plant-based vaccines are cost-effective to produce large quantities; they are easy to store, handling is easy, easy to expand the production scale, can be taken orally or through the mucosal route.

Related associations and societies: National Institutes of Health (NIH) , Federation of Clinical Immunology Societies (FOCIS), Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), Clinical Immunology Society, Hepatitis B Foundation (HBF), Pediatric Infectious Diseases Society(PIDS), National Institute of Allergy and Infectious Diseases (NIAID), Indian Vaccine Manufacturers Association (IVMA), National Medical Association (NMA), Immune Deficiency Foundation (IDF)